Insights

Recent articles, reports, and other media from Velocity

Paul Evans, Nadege Gunn Featured in ACRP Trend Prediction Article

January 11, 2024

Paul Evans, President and CEO and Nadege Gunn, MD, CPI, Medical Director and Senior Scientific Advisor for Velocity are highlighted in a recent article by the ACRP, The Year Ahead in Trends, Challenges, and Opportunities for Clinical Trial Sites. In the article, Dr. Gunn shares her hope for Sponsors and CROs “to fund a long-term … Read more

Video: Demand and Delivery

January 9, 2024

Watch Christy Godwin and Laura Falcone discuss Velocity’s unique ‘Demand and Delivery’ approach. Christy and Laura work in unison to ensure full alignment among what Sponsors and CROs demand, and the quality, performance, and patient experiences Velocity delivers. In this video, they delve into: The importance of understanding goals and translating them into actionable strategies … Read more

Video: Scale for a Purpose

January 3, 2024

A staggering 80% of clinical trials are delayed or shut down due to enrollment challenges, with half of those delays occurring at the site level. Two-thirds of principal investigators leave research after conducting a single trial. It’s time for a change. Watch Paul Evans, Nick Campbell, Nick Spittal, and Craig Koch discuss Velocity’s unique model, … Read more

Velocity Eczema Trials Enhance Patient Quality of Life

October 20, 2023

Shiva Muthiah, Director of UK Operations for Velocity, smiles as she recalls the triumph of a teenage patient battling a painful eczema skin condition. “He used to wear long sleeves and other clothing designed to hide the marks on his skin, but almost immediately after beginning treatment in our clinical trial, the improvement was dramatic … Read more

Velocity Tackles Back Pain with Digital Innovation in Germany

August 8, 2023

More than ever, most of us have jobs that involve sitting at a desk for hours on end. The average desk worker in the U.S. is 36 years old and female. While some companies invest in workstation assessments, a lot of us are still working from home where we are less likely to have invested … Read more

Velocity PAC Insights: Revamping Clinical Trial Experiences 

August 2, 2023

At Velocity Clinical Research, we prioritize the voices of clinical trial participants, largely via the Participant Advisory Committee (PAC). Our PAC, which brings together a diverse group of past and current trial participants from across the U.S., offers a unique lens into the clinical research process. In this edition, we’ll unpack key insights gleaned from … Read more

Velocity Launches Innovative CARE Council Model, Debuts With Focus On Diabetes and Obesity Clinical Trials

August 1, 2023

Velocity Clinical Research, the leading integrated site organization for clinical trials, has launched a groundbreaking initiative: Councils to Accelerate Research Excellence (CARE Councils). The CARE Councils underpin Velocity’s dedication to supporting specialty research while providing comprehensive and strategically aligned solutions for Sponsors and CROs. The expert-led CARE Councils bring together seasoned physicians in their areas … Read more

PI Focus: Building Relationships Through Clinical Trials in the United Kingdom

July 18, 2023

For the team at Velocity Clinical Research in the United Kingdom, clinical trials are first and foremost about building relationships.  “I’m really grateful to be involved in clinical trials, because it allows me to develop meaningful connections with people in a way that goes beyond the traditional and [usually] more formal doctor-patient relationship,” says Ahmed … Read more

PI Focus: Passion for Research, Strong Team Key to Long-Term PI Success

June 29, 2023

With nearly three decades as a family physician and almost 25 years as a Principal Investigator (PI), Frank Eder, MD, believes two primary elements are critical for sustained success in clinical research.  “You must have a true interest in the research side of it. You have to actually be interested in the science and the … Read more

Velocity Investigators Active at the American Diabetes Association (ADA) 83rd Scientific Sessions

June 27, 2023

Julio Rosenstock, MD, and Juan Frias, MD, were featured prominently throughout the American Diabetes Association (ADA) 83rd Scientific Sessions. The prolific researchers also had findings simultaneously published in the New England Journal of Medicine and The Lancet. Dr. Rosenstock is the lead investigator for Novo Nordisk’s ONWARDS 1 program exploring the first investigational once-weekly insulin. … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Quality. Continuity. Velocity.